Cath Mummery About University College London View catherine mummery’s profile on linkedin, a professional community of 1 billion members. She is head of novel therapeutics at the dementia research centre, ucl and has been senior investigator on over 20 early phase drug trials of disease modifying agents in dementias including genetic forms of alzheimer’s disease and frontotemporal dementia.
Dr Catherine Mummery On Ucl S Groundbreaking Research Into Gene As clinical lead for the ucl neurogenetic therapies programme, she leads a programme of innovative collaboration between industry and academia to accelerate progress in genetic therapies in. View the university college london profile of cath mummery. including their outputs and professional activities. As clinical lead for the ucl neurogenetic therapies programme, i lead a programme of innovative collaboration between industry and academia to accelerate progress in genetic therapies in dementia. Dr catherine mummery is the head of novel therapeutics at the ucl dementia research centre and is also a consultant neurologist at the national hospital for neurology and neurosurgery.
Dr Catherine Mummery On Ucl S Groundbreaking Research Into Gene As clinical lead for the ucl neurogenetic therapies programme, i lead a programme of innovative collaboration between industry and academia to accelerate progress in genetic therapies in dementia. Dr catherine mummery is the head of novel therapeutics at the ucl dementia research centre and is also a consultant neurologist at the national hospital for neurology and neurosurgery. Catherine mummery | cited by 934 | of university college london hospitals nhs foundation trust, london (uclh) | read 10 publications | contact catherine mummery. Catherine mummery head of clinical trials, dementia research centre, ucl; chair nihr dementia translational research collaboration 2y. I'm honoured to lead this exciting uk initiative to accelerate therapies in dementia, building a world class early phase trials network, expanding uk's incredible research expertise, improving. She is head of clinical trials at the dementia research centre at ucl. she has been chief investigator in over 20 early phase drug trials of potential disease modifying agents in sporadic alzheimer’s disease (ad), genetic forms of ad and frontotemporal dementia.
Dr Catherine Mummery On Ucl S Groundbreaking Research Into Gene Catherine mummery | cited by 934 | of university college london hospitals nhs foundation trust, london (uclh) | read 10 publications | contact catherine mummery. Catherine mummery head of clinical trials, dementia research centre, ucl; chair nihr dementia translational research collaboration 2y. I'm honoured to lead this exciting uk initiative to accelerate therapies in dementia, building a world class early phase trials network, expanding uk's incredible research expertise, improving. She is head of clinical trials at the dementia research centre at ucl. she has been chief investigator in over 20 early phase drug trials of potential disease modifying agents in sporadic alzheimer’s disease (ad), genetic forms of ad and frontotemporal dementia.
Dr Catherine Mummery On Ucl S Groundbreaking Research Into Gene I'm honoured to lead this exciting uk initiative to accelerate therapies in dementia, building a world class early phase trials network, expanding uk's incredible research expertise, improving. She is head of clinical trials at the dementia research centre at ucl. she has been chief investigator in over 20 early phase drug trials of potential disease modifying agents in sporadic alzheimer’s disease (ad), genetic forms of ad and frontotemporal dementia.
Dr Catherine Mummery On Ucl S Groundbreaking Research Into Gene
Comments are closed.